| Mr Christopher Charles Linderman, DNP | |
|
202 N Division St, Auburn, WA 98001-4939 | |
| (253) 545-2050 | |
| Not Available |
| Full Name | Mr Christopher Charles Linderman |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 202 N Division St, Auburn, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548885916 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | AP61092215 (Washington) | Primary |
| 163W00000X | Registered Nurse | RN60130171 (Washington) | Secondary |
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Actinium's Clinical Advisory Board Chairman Joseph Jurcic, MD will participate in an upcoming panel discussion highlighting the role of Actinium's alpha-particle radiopharmaceuticals in the treatment of leukemia patients.
BGI Diagnostics' NIFTY™ test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA).
...eleven times the rate in the general population, according to a study in the August issue of Archives of General Psychiatry.
› Verified 2 days ago
| Entity Name | Recovery Innovations, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659880078 PECOS PAC ID: 1456500628 Enrollment ID: O20121003000257 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Actinium's Clinical Advisory Board Chairman Joseph Jurcic, MD will participate in an upcoming panel discussion highlighting the role of Actinium's alpha-particle radiopharmaceuticals in the treatment of leukemia patients.
BGI Diagnostics' NIFTY™ test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA).
...eleven times the rate in the general population, according to a study in the August issue of Archives of General Psychiatry.
› Verified 2 days ago
| Entity Name | Geriatric Psychiatry Northwest Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427709443 PECOS PAC ID: 2567859747 Enrollment ID: O20220419001455 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Actinium's Clinical Advisory Board Chairman Joseph Jurcic, MD will participate in an upcoming panel discussion highlighting the role of Actinium's alpha-particle radiopharmaceuticals in the treatment of leukemia patients.
BGI Diagnostics' NIFTY™ test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA).
...eleven times the rate in the general population, according to a study in the August issue of Archives of General Psychiatry.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher Charles Linderman, DNP 15412 48th Street Ct E, Sumner, WA 98390-2835 Ph: (253) 905-6877 | Mr Christopher Charles Linderman, DNP 202 N Division St, Auburn, WA 98001-4939 Ph: (253) 545-2050 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Actinium's Clinical Advisory Board Chairman Joseph Jurcic, MD will participate in an upcoming panel discussion highlighting the role of Actinium's alpha-particle radiopharmaceuticals in the treatment of leukemia patients.
BGI Diagnostics' NIFTY™ test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA).
...eleven times the rate in the general population, according to a study in the August issue of Archives of General Psychiatry.
› Verified 2 days ago
Deborah Ann Coughlin, ARNP: AP30007936 Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1340 M St Se, Suite A, Auburn, WA 98002 Phone: 253-735-2777 Fax: 253-735-4153 | |
Mrs. Alicia Austria Paraiso, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20 Auburn Ave, Auburn, WA 98002 Phone: 206-205-6855 Fax: 206-296-8403 | |
Mrs. Oanh Thi Lam, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 31510 120th Ct Se, Auburn, WA 98092 Phone: 315-399-7573 | |
Ms. Lucie Mckee, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 E Main St, Suite 100, Auburn, WA 98002 Phone: 253-939-9654 Fax: 253-939-6549 | |
Linda Josephine Matthews, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 29224 120th Way Se, Auburn, WA 98092 Phone: 206-249-5440 | |
Ms. Jennifer Christine Drake, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4240 Auburn Way N, Sound Mental Health, Auburn, WA 98002 Phone: 253-876-8900 Fax: 253-876-8910 | |
Dixie Leah Reynolds, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 202 N Division St Ste 202, Auburn, WA 98001 Phone: 253-876-8088 |